{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:56:37Z","timestamp":1788479797678,"version":"build-2803163510"},"reference-count":45,"publisher":"China Science Publishing & Media Ltd.","issue":"7","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.3724\/abbs.2024230","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T01:31:52Z","timestamp":1733707912000},"page":"1151-1163","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["AKR1C3 protects cardiomyocytes against hypoxia-induced cell apoptosis through the Nrf-2\/NF-κB pathway"],"prefix":"10.3724","volume":"57","author":[{"given":"Wenlu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"Tsao CW","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM. Heart disease and stroke statistics\u20142023 update: a report from the american heart association. Circulation, 2023, 147: e93-e621.","journal-title":"Circulation"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jjcc.2012.05.014","volume":"60","author":"Hojo Y","year":"2012","unstructured":"Hojo Y, Saito T, Kondo H. Role of apoptosis in left ventricular remodeling after acute myocardial infarction. J Cardiol, 2012, 60: 91-92.","journal-title":"J Cardiol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.7150\/ijbs.39414","volume":"16","author":"Wei L","year":"2020","unstructured":"Wei L, Zhou Q, Tian H, Su Y, Fu G, Sun T. Integrin \u03b23 promotes cardiomyocyte proliferation and attenuates hypoxia-induced apoptosis via regulating the PTEN\/Akt\/mTOR and ERK1\/2 pathways. Int J Biol Sci, 2020, 16: 644-654.","journal-title":"Int J Biol Sci"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/07853890.2017.1417631","volume":"50","author":"Chistiakov DA","year":"2018","unstructured":"Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN. The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Ann Med, 2018, 50: 121-127.","journal-title":"Ann Med"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"Zorov DB","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev, 2014, 94: 909-950.","journal-title":"Physiol Rev"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s12276-022-00800-5","volume":"54","author":"Qi B","year":"2022","unstructured":"Qi B, Song L, Hu L, Guo D, Ren G, Peng T, Liu M. Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis. Exp Mol Med, 2022, 54: 946-960.","journal-title":"Exp Mol Med"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1021\/jm300841n","volume":"55","author":"Bro\u017ei\u010d P","year":"2012","unstructured":"Bro\u017ei\u010d P, Turk S, Adeniji AO, Konc J, Jane\u017ei\u010d D, Penning TM, Lani\u0161nik Ri\u017ener T. Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library. J Med Chem, 2012, 55: 7417-7424.","journal-title":"J Med Chem"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mce.2018.07.002","volume":"489","author":"Penning TM","year":"2019","unstructured":"Penning TM. AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): roles in malignancy and endocrine disorders. Mol Cell Endocrinol, 2019, 489: 82-91.","journal-title":"Mol Cell Endocrinol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1158\/1078-0432.CCR-14-2352","volume":"21","author":"Powell K","year":"2015","unstructured":"Powell K, Semaan L, Conley-LaComb MK, Asangani I, Wu YM, Ginsburg KB, Williams J. ERG\/AKR1C3\/AR constitutes a feed-forward loop for AR signaling in prostate cancer cells. Clin Cancer Res, 2015, 21: 2569-2579.","journal-title":"Clin Cancer Res"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41388-022-02566-6","volume":"42","author":"Yang JC","year":"2023","unstructured":"Yang JC, Xu P, Ning S, Wasielewski LJ, Adomat H, Hwang SH, Morisseau C. Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer. Oncogene, 2023, 42: 693-707.","journal-title":"Oncogene"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-20-2480","volume":"81","author":"Zhou Q","year":"2021","unstructured":"Zhou Q, Tian W, Jiang Z, Huang T, Ge C, Liu T, Zhao F. A positive feedback loop of AKR1C3-mediated activation of NF-\u03baB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma. Cancer Res, 2021, 81: 1361-1374.","journal-title":"Cancer Res"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mc.23527","volume":"62","author":"Chen J","year":"2023","unstructured":"Chen J, Zhang J, Tian W, Ge C, Su Y, Li J, Tian H. AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway. Mol Carcinog, 2023, 62: 833-844.","journal-title":"Mol Carcinog"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3390\/cancers13102403","volume":"13","author":"Zhou C","year":"2021","unstructured":"Zhou C, Wang Z, Li J, Wu X, Fan N, Li D, Liu F. Aldo-keto reductase 1C3 mediates chemotherapy resistance in esophageal adenocarcinoma via ROS detoxification. Cancers, 2021, 13:","journal-title":"Cancers"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/acs.jmedchem.9b02138","volume":"63","author":"Liu Y","year":"2020","unstructured":"Liu Y, He S, Chen Y, Liu Y, Feng F, Liu W, Guo Q. Overview of AKR1C3: inhibitor achievements and disease insights. J Med Chem, 2020, 63: 11305-11329.","journal-title":"J Med Chem"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1160\/TH10-03-0195","volume":"104","author":"Giannarelli C","year":"2010","unstructured":"Giannarelli C, Zafar MU, Badimon J. Prostanoid and TP-receptors in atherothrombosis: is there a role for their antagonism?. Thromb Haemost, 2010, 104: 949-954.","journal-title":"Thromb Haemost"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.3390\/ijms20174262","volume":"20","author":"Khan S","year":"2019","unstructured":"Khan S, Andrews KL, Chin-Dusting JPF. Cyclo-oxygenase (COX) inhibitors and cardiovascular risk: are non-steroidal anti-inflammatory drugs really anti-inflammatory?. Int J Mol Sci, 2019, 20:","journal-title":"Int J Mol Sci"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8880004","volume":"2020","author":"Xie H","year":"2020","unstructured":"Xie H, Zha E, Zhang Y, Sakowicz A. Identification of featured metabolism-related genes in patients with acute myocardial infarction. Dis Markers, 2020, 2020: 1-9.","journal-title":"Dis Markers"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-024-03062-3","volume":"43","author":"Su Y","year":"2024","unstructured":"Su Y, Meng L, Ge C, Liu Y, Zhang C, Yang Y, Tian W. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling. J Exp Clin Cancer Res, 2024, 43:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.jhepr.2024.101217","volume":"7","author":"Li J","year":"2025","unstructured":"Li J, Zhang C, Zhou Q, Long Q, Chen J, Meng L, Tian W. ALDH1L2 drives HCC progression through TAM polarization. JHEP Rep, 2025, 7:","journal-title":"JHEP Rep"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/med.21396","volume":"36","author":"Lu MC","year":"2016","unstructured":"Lu MC, Ji JA, Jiang ZY, You QD. The keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev, 2016, 36: 924-963.","journal-title":"Med Res Rev"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","volume":"22","author":"Kucharczak J","year":"2003","unstructured":"Kucharczak J, Simmons MJ, Fan Y, G\u00e9linas C. To be, or not to be: NF-\u03baB is the answer-role of Rel\/NF-\u03baB in the regulation of apoptosis. Oncogene, 2003, 22: 8961-8982.","journal-title":"Oncogene"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.118.038379","volume":"143","author":"Karunakaran D","year":"2021","unstructured":"Karunakaran D, Nguyen MA, Geoffrion M, Vreeken D, Lister Z, Cheng HS, Otte N. RIPK1 expression associates with inflammation in early atherosclerosis in humans and can be therapeutically silenced to reduce NF-\u03baB activation and atherogenesis in mice. Circulation, 2021, 143: 163-177.","journal-title":"Circulation"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"Morgan MJ","year":"2011","unstructured":"Morgan MJ, Liu Z. Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res, 2011, 21: 103-115.","journal-title":"Cell Res"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/416036","volume":"2012","author":"Lee J","year":"2012","unstructured":"Lee J, Rhee MH, Kim E, Cho JY. BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediators Inflamm, 2012, 2012: 1-11.","journal-title":"Mediators Inflamm"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5551\/jat.RV17009","volume":"24","author":"Abe H","year":"2017","unstructured":"Abe H, Semba H, Takeda N. The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb, 2017, 24: 884-894.","journal-title":"J Atheroscler Thromb"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.2518","volume":"218","author":"Sluimer JC","year":"2009","unstructured":"Sluimer JC, Daemen MJ. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol, 2009, 218: 7-29.","journal-title":"J Pathol"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3724\/abbs.2023277","volume":"56","author":"Yan Z","year":"2024","unstructured":"Yan Z, Liu Y, Yang B, Zhao W, Wang Y, Wang D, Li J. Endoplasmic reticulum stress caused by traumatic injury promotes cardiomyocyte apoptosis through acetylation modification of GRP78. Acta Biochim Biophys Sin, 2024, 56: 96-105.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3724\/abbs.2024130","volume":"56","author":"Yu K","year":"2024","unstructured":"Yu K, Su X, Zhou T, Cai X, Zhang M. EEPD1 attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading FOXO3A in cardiomyocytes. Acta Biochim Biophys Sin, 2024, 56: 1733-1747.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1161\/CIRCRESAHA.122.321153","volume":"132","author":"Yang Y","year":"2023","unstructured":"Yang Y, Zhang Y, Yang J, Zhang M, Tian T, Jiang Y, Liu X. Interdependent nuclear Co-trafficking of ASPP1 and p53 aggravates cardiac ischemia\/reperfusion injury. Circ Res, 2023, 132: 208-222.","journal-title":"Circ Res"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/eurheartj\/ehv126","volume":"36","author":"Karimi Galougahi K","year":"2015","unstructured":"Karimi Galougahi K, Antoniades C, Nicholls SJ, Channon KM, Figtree GA. Redox biomarkers in cardiovascular medicine. Eur Heart J, 2015, 36: 1576-1582.","journal-title":"Eur Heart J"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"Tsutsui H","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol-Heart Circulatory Physiol, 2011, 301: H2181-H2190.","journal-title":"Am J Physiol-Heart Circulatory Physiol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","volume":"192","author":"Zorov DB","year":"2000","unstructured":"Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ros-induced) ros release. J Exp Med, 2000, 192: 1001-1014.","journal-title":"J Exp Med"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"472.e11","DOI":"10.1016\/j.urolonc.2018.07.005","volume":"36","author":"Wang B","year":"2018","unstructured":"Wang B, Gu Y, Hui K, Huang J, Xu S, Wu S, Li L. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. Urologic Oncol-Semin Original Invests, 2018, 36: 472.e11-472.e20.","journal-title":"Urologic Oncol-Semin Original Invests"},{"key":"CITATION34","unstructured":"Jin Y, Sun C, Zhang W. Effects of AKR1C3 on kidney damage of preeclamptic rats. Zhonghua Yi Xue Za Zhi 2015, 95: 30\u201333."},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"694238","DOI":"10.3389\/fcvm.2021.694238","volume":"8","author":"Liang J","year":"2021","unstructured":"Liang J, Cao Y, He M, Li W, Huang G, Ma T, Li M. AKR1C3 and its transcription factor HOXB4 are promising diagnostic biomarkers for acute myocardial infarction. Front Cardiovasc Med, 2021, 8:","journal-title":"Front Cardiovasc Med"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"Loboda A","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci, 2016, 73: 3221-3247.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/03602530600971974","volume":"38","author":"Zhang DD","year":"2006","unstructured":"Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev, 2006, 38: 769-789.","journal-title":"Drug Metab Rev"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1038\/s41388-022-02379-7","volume":"41","author":"Pan D","year":"2022","unstructured":"Pan D, Yang W, Zeng Y, Qin H, Xu Y, Gui Y, Fan X. AKR1C3 regulated by NRF2\/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma. Oncogene, 2022, 41: 3846-3858.","journal-title":"Oncogene"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1362564","DOI":"10.3389\/fcvm.2024.1362564","volume":"11","author":"Marriott E","year":"2024","unstructured":"Marriott E, Singanayagam A, El-Awaisi J. Inflammation as the nexus: Exploring the link between acute myocardial infarction and chronic obstructive pulmonary disease. Front Cardiovasc Med, 2024, 11:","journal-title":"Front Cardiovasc Med"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","volume":"181","author":"Innamorato NG","year":"2008","unstructured":"Innamorato NG, Rojo AI, Garci\u0301a-Yagu\u0308e AJ, Yamamoto M, de Ceballos ML, Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol, 2008, 181: 680-689.","journal-title":"J Immunol"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1172\/JCI25790","volume":"116","author":"Thimmulappa RK","year":"2006","unstructured":"Thimmulappa RK. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest, 2006, 116: 984-995.","journal-title":"J Clin Invest"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","volume":"289","author":"Cuadrado A","year":"2014","unstructured":"Cuadrado A, Mart\u00edn-Moldes Z, Ye J, Lastres-Becker I. Transcription factors NRF2 and NF-\u03baB are coordinated effectors of the rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem, 2014, 289: 15244-15258.","journal-title":"J Biol Chem"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"Hayden MS","year":"2008","unstructured":"Hayden MS, Ghosh S. Shared principles in NF-\u03baB signaling. Cell, 2008, 132: 344-362.","journal-title":"Cell"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cardiores.2004.03.002","volume":"63","author":"Onai Y","year":"2004","unstructured":"Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fukasawa H, Muto S. Inhibition of I\u03baB phosphorylation in cardiomyocytes attenuates myocardial ischemia\/reperfusion injury. Cardiovasc Res, 2004, 63: 51-59.","journal-title":"Cardiovasc Res"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1536\/ihj.51.348","volume":"51","author":"Kim YS","year":"2010","unstructured":"Kim YS, Kim JS, Kwon JS, Jeong MH, Cho JG, Park JC, Kang JC. BAY 11-7082, a nuclear factor-\u03baB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model. Int Heart J, 2010, 51: 348-353.","journal-title":"Int Heart J"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/C2736CF1B9394349943AD219FFFE08D6","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024230","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/C2736CF1B9394349943AD219FFFE08D6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T03:11:27Z","timestamp":1757646687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2024230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,6]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024230","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}